(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Oncternal Therapeutics, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, April 26th, 2024 | 2023 | Richard G. Vincent | 436,126 | 0 | 0 | 153,517 | 13,200 | 847,909 |
| Friday, April 26th, 2024 | 2023 | Salim Yazji, M.D. Chief Medical Officer | 471,310 | 0 | 0 | 164,016 | 13,200 | 903,693 |
| Friday, April 26th, 2024 | 2022 | Salim Yazji, M.D. Chief Medical Officer | 448,866 | 0 | 224,643 | 159,797 | 12,200 | 1,034,123 |
| Friday, April 26th, 2024 | 2022 | James B. Breitmeyer, M.D., Ph.D. President Chief Executive Officer | 579,873 | 0 | 505,444 | 260,943 | 12,200 | 2,446,248 |
| Friday, April 26th, 2024 | 2023 | James B. Breitmeyer, M.D., Ph.D. President Chief Executive Officer | 609,386 | 0 | 0 | 258,769 | 13,200 | 1,623,074 |
| Tuesday, May 16th, 2023 | 2021 | Salim Yazji, M.D. Chief Medical Officer | 264,518 | 0 | 0 | 88,140 | 0 | 2,015,428 |
| Tuesday, May 16th, 2023 | 2021 | James B. Breitmeyer, M.D., Ph.D. President Chief Executive Officer | 556,500 | 0 | 0 | 222,600 | 0 | 4,680,675 |
| Tuesday, May 16th, 2023 | 2022 | James B. Breitmeyer, M.D., Ph.D. President Chief Executive Officer | 579,873 | 0 | 505,444 | 222,600 | 12,200 | 2,407,905 |
| Tuesday, May 16th, 2023 | 2022 | Gunnar F. Kaufmann, Ph.D. Chief Scientific Officer | 415,948 | 0 | 117,427 | 132,788 | 0 | 941,210 |
| Tuesday, May 16th, 2023 | 2022 | Salim Yazji, M.D. Chief Medical Officer | 448,866 | 0 | 224,643 | 88,140 | 12,200 | 962,466 |
| Friday, April 29th, 2022 | 2020 | James B. Breitmeyer, M.D., Ph.D. President Chief Executive Officer | 530,000 | 1,000 | 0 | 249,100 | 0 | 780,100 |
| Friday, April 29th, 2022 | 2021 | Salim Yazji, M.D. Chief Medical Officer | 264,518 | 0 | 0 | 88,140 | 0 | 2,015,428 |
| Friday, April 29th, 2022 | 2021 | Richard G. Vincent | 393,750 | 0 | 0 | 130,725 | 0 | 1,981,063 |
| Friday, April 29th, 2022 | 2021 | James B. Breitmeyer, M.D., Ph.D. President Chief Executive Officer | 556,500 | 0 | 0 | 222,600 | 0 | 4,680,675 |
| Tuesday, April 13th, 2021 | 2020 | James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer | 530,000 | 1,000 | 0 | 249,100 | 1,702 | 781,802 |
| Tuesday, April 13th, 2021 | 2019 | Frank J. Hsu, M.D. Former Chief Medical Officer | 139,583 | 0 | 0 | 42,643 | 18,417 | 769,143 |
| Tuesday, April 13th, 2021 | 2020 | Frank J. Hsu, M.D. Former Chief Medical Officer | 400,000 | 1,000 | 0 | 133,760 | 20,960 | 555,720 |
| Tuesday, April 13th, 2021 | 2019 | Gunnar F. Kaufmann, Ph.D. Chief Scientific Officer | 122,444 | 0 | 0 | 37,361 | 0 | 683,305 |
| Tuesday, April 13th, 2021 | 2020 | Gunnar F. Kaufmann, Ph.D. Chief Scientific Officer | 380,000 | 1,000 | 0 | 143,184 | 1,702 | 525,886 |
| Tuesday, April 13th, 2021 | 2019 | James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer | 501,588 | 0 | 0 | 225,250 | 0 | 1,115,838 |
| Wednesday, April 29th, 2020 | 2018 | Hazel M. Aker General Counsel | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 29th, 2020 | 2019 | Henry P. Doggrell Former Vice President, Chief Legal Officer and Secretary | 186,268 | 0 | 0 | 0 | 406,701 | 592,969 |
| Wednesday, April 29th, 2020 | 2018 | Frank J. Hsu, M.D. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, April 29th, 2020 | 2019 | Hazel M. Aker General Counsel | 150,000 | 0 | 0 | 59,020 | 20,700 | 813,220 |
| Wednesday, April 29th, 2020 | 2019 | Marc S. Hanover Former President and Chief Executive Officer | 213,130 | 0 | 0 | 0 | 445,628 | 658,759 |
| Wednesday, April 29th, 2020 | 2018 | Henry P. Doggrell Former Vice President, Chief Legal Officer and Secretary | 389,463 | 0 | 0 | 54,525 | 24,836 | 925,736 |
| Wednesday, April 29th, 2020 | 2019 | Frank J. Hsu, M.D. Chief Medical Officer | 139,583 | 0 | 0 | 42,643 | 18,417 | 769,143 |
| Wednesday, April 29th, 2020 | 2018 | Marc S. Hanover Former President and Chief Executive Officer | 445,628 | 0 | 0 | 115,863 | 22,338 | 1,243,813 |
| Wednesday, April 29th, 2020 | 2019 | James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer | 501,588 | 0 | 0 | 225,250 | 0 | 1,115,838 |
| Wednesday, April 29th, 2020 | 2018 | James B. Breitmeyer, M.D., Ph.D. President and Chief Executive Officer | 426,028 | 0 | 0 | 0 | 0 | 518,028 |
| Friday, March 23rd, 2018 | 2016 | Marc S. Hanover Chief Executive Officer | 432,649 | 28,122 | 0 | 140,611 | 19,392 | 841,734 |
| Friday, March 23rd, 2018 | 2016 | Robert J. Wills Executive Chairman | 220,000 | 14,300 | 0 | 71,500 | 29,459 | 556,219 |
| Friday, March 23rd, 2018 | 2017 | Henry P. Doggrell Vice President, Chief Legal | 378,119 | 13,234 | 0 | 72,788 | 21,996 | 778,337 |
| Friday, March 23rd, 2018 | 2016 | Henry P. Doggrell Vice President, Chief Legal | 378,119 | 13,234 | 0 | 66,171 | 21,796 | 617,420 |
| Friday, March 23rd, 2018 | 2017 | Marc S. Hanover Chief Executive Officer | 432,649 | 28,122 | 0 | 154,672 | 21,586 | 984,017 |
| Friday, March 23rd, 2018 | 2017 | Robert J. Wills Executive Chairman | 220,000 | 14,300 | 0 | 78,650 | 31,268 | 691,206 |
| Friday, March 31st, 2017 | 2016 | Marc S. Hanover Chief Executive | 432,649 | 28,122 | 0 | 140,611 | 19,392 | 841,734 |
| Friday, March 31st, 2017 | 2016 | Robert J. Wills Executive Chairman | 220,000 | 14,300 | 0 | 71,500 | 29,459 | 556,219 |
| Friday, March 31st, 2017 | 2015 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 330,000 | 0 | 21,205 | 714,781 |
| Friday, March 31st, 2017 | 2015 | Robert J. Wills Executive Chairman | 169,231 | 0 | 750,000 | 0 | 28,571 | 947,802 |
| Friday, March 31st, 2017 | 2015 | Marc S. Hanover Chief Executive | 393,317 | 0 | 495,000 | 0 | 17,758 | 906,075 |
| Friday, March 31st, 2017 | 2016 | Henry P. Doggrell Vice President, Chief Legal | 378,119 | 13,234 | 0 | 66,171 | 21,796 | 617,420 |
| Monday, March 28th, 2016 | 2015 | Marc S. Hanover Chief Executive Officer | 393,317 | 0 | 495,000 | 0 | 17,758 | 906,075 |
| Monday, March 28th, 2016 | 2013 | Marc S. Hanover Chief Executive Officer | 466,685 | 0 | 0 | 0 | 21,442 | 741,009 |
| Monday, March 28th, 2016 | 2013 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 188,000 | 0 | 23,469 | 865,634 |
| Monday, March 28th, 2016 | 2015 | Robert J. Wills Executive Chairman | 169,231 | 0 | 750,000 | 0 | 28,571 | 947,802 |
| Monday, March 28th, 2016 | 2014 | Marc S. Hanover Chief Executive Officer | 393,317 | 0 | 0 | 127,828 | 19,380 | 1,385,300 |
| Monday, March 28th, 2016 | 2015 | Jason T. Shackelford Senior Director, Accounting and Corporate Controller | 210,000 | 0 | 198,000 | 0 | 9,450 | 417,450 |
| Monday, March 28th, 2016 | 2014 | Jason T. Shackelford Senior Director, Accounting and Corporate Controller | 199,365 | 89,005 | 0 | 26,250 | 10,400 | 515,978 |
| Monday, March 28th, 2016 | 2013 | Jason T. Shackelford Senior Director, Accounting and Corporate Controller | 178,010 | 0 | 94,000 | 0 | 7,115 | 437,064 |
| Monday, March 28th, 2016 | 2015 | Diane C. Young, M.D. | 84,135 | 0 | 705,000 | 0 | 11,798 | 800,933 |
| Monday, March 28th, 2016 | 2015 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 330,000 | 0 | 21,205 | 714,781 |
| Monday, March 28th, 2016 | 2014 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 181,788 | 0 | 63,626 | 21,005 | 833,375 |
| Thursday, March 26th, 2015 | 2014 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 181,788 | 0 | 63,626 | 21,005 | 833,375 |
| Thursday, March 26th, 2015 | 2013 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 188,000 | 0 | 23,469 | 865,634 |
| Thursday, March 26th, 2015 | 2012 | James T. Dalton, Ph.D. Former Vice President, Chief Scientific Officer | 416,000 | 0 | 0 | 72,384 | 17,992 | 581,185 |
| Thursday, March 26th, 2015 | 2013 | James T. Dalton, Ph.D. Former Vice President, Chief Scientific Officer | 416,456 | 0 | 188,000 | 0 | 18,636 | 913,681 |
| Thursday, March 26th, 2015 | 2014 | James T. Dalton, Ph.D. Former Vice President, Chief Scientific Officer | 249,519 | 187,500 | 0 | 0 | 41,256 | 489,694 |
| Thursday, March 26th, 2015 | 2012 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 351,281 | 0 | 0 | 61,123 | 19,719 | 506,932 |
| Thursday, March 26th, 2015 | 2012 | Marc S. Hanover Chief Executive Officer | 475,020 | 0 | 0 | 151,531 | 20,115 | 796,284 |
| Thursday, March 26th, 2015 | 2012 | Mitchell S. Steiner, M.D., F.A.C.S. Former Chief Executive Officer | 546,000 | 0 | 0 | 205,842 | 13,771 | 990,040 |
| Thursday, March 26th, 2015 | 2014 | Mitchell S. Steiner, M.D., F.A.C.S. Former Chief Executive Officer | 139,104 | 0 | 0 | 0 | 488,887 | 986,639 |
| Thursday, March 26th, 2015 | 2013 | Marc S. Hanover Chief Executive Officer | 466,685 | 0 | 0 | 0 | 21,442 | 741,009 |
| Thursday, March 26th, 2015 | 2014 | Jason T. Shackelford Senior Director, Accounting and Corporate Controller | 199,365 | 89,005 | 0 | 26,250 | 10,400 | 515,978 |
| Thursday, March 26th, 2015 | 2014 | Marc S. Hanover Chief Executive Officer | 393,317 | 0 | 0 | 127,828 | 19,380 | 1,385,300 |
| Thursday, March 26th, 2015 | 2013 | Mitchell S. Steiner, M.D., F.A.C.S. Former Chief Executive Officer | 536,420 | 0 | 0 | 0 | 15,692 | 931,435 |
| Monday, March 24th, 2014 | 2013 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 536,420 | 0 | 0 | 0 | 15,692 | 931,435 |
| Monday, March 24th, 2014 | 2013 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 363,576 | 0 | 188,000 | 0 | 23,469 | 865,634 |
| Monday, March 24th, 2014 | 2012 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 351,281 | 0 | 0 | 61,123 | 19,719 | 506,932 |
| Monday, March 24th, 2014 | 2011 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 525,000 | 170,625 | 0 | 0 | 10,030 | 879,619 |
| Monday, March 24th, 2014 | 2013 | Marc S. Hanover President, Chief Operating Officer and acting Principal Financial Officer | 466,685 | 0 | 0 | 0 | 21,442 | 741,009 |
| Monday, March 24th, 2014 | 2012 | Marc S. Hanover President, Chief Operating Officer and acting Principal Financial Officer | 475,020 | 0 | 0 | 151,531 | 20,115 | 796,284 |
| Monday, March 24th, 2014 | 2013 | Mark E. Mosteller, CPA Former Vice President, Chief Financial Officer and Treasurer | 320,857 | 0 | 0 | 0 | 276,729 | 878,285 |
| Monday, March 24th, 2014 | 2012 | Mark E. Mosteller, CPA Former Vice President, Chief Financial Officer and Treasurer | 310,006 | 0 | 0 | 53,941 | 14,050 | 452,806 |
| Monday, March 24th, 2014 | 2011 | Mark E. Mosteller, CPA Former Vice President, Chief Financial Officer and Treasurer | 298,083 | 44,712 | 0 | 0 | 12,910 | 413,693 |
| Monday, March 24th, 2014 | 2011 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 343,589 | 52,962 | 0 | 0 | 18,974 | 473,513 |
| Monday, March 24th, 2014 | 2012 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 546,000 | 0 | 0 | 205,842 | 13,771 | 990,040 |
| Monday, March 24th, 2014 | 2013 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 416,456 | 0 | 188,000 | 0 | 18,636 | 913,681 |
| Monday, March 24th, 2014 | 2012 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 416,000 | 0 | 0 | 72,384 | 17,992 | 581,185 |
| Monday, March 24th, 2014 | 2011 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 400,000 | 60,000 | 0 | 0 | 15,840 | 558,680 |
| Monday, March 24th, 2014 | 2011 | Marc S. Hanover President, Chief Operating Officer and acting Principal Financial Officer | 456,750 | 125,606 | 0 | 0 | 18,389 | 716,721 |
| Friday, March 15th, 2013 | 2011 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 44,712 | 0 | 0 | 12,910 | 413,693 |
| Friday, March 15th, 2013 | 2012 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 310,006 | 0 | 0 | 53,941 | 14,050 | 452,806 |
| Friday, March 15th, 2013 | 2012 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 416,000 | 0 | 0 | 72,384 | 17,992 | 581,185 |
| Friday, March 15th, 2013 | 2012 | Henry P. Doggrell Vice President, Chief Legal Officer and Secretary | 351,281 | 0 | 0 | 61,123 | 19,719 | 506,932 |
| Friday, March 15th, 2013 | 2010 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 400,000 | 0 | 0 | 0 | 16,409 | 509,506 |
| Friday, March 15th, 2013 | 2012 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 546,000 | 0 | 0 | 205,842 | 13,771 | 990,040 |
| Friday, March 15th, 2013 | 2011 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer | 400,000 | 60,000 | 0 | 0 | 15,840 | 558,680 |
| Friday, March 15th, 2013 | 2010 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 0 | 0 | 0 | 18,389 | 661,332 |
| Friday, March 15th, 2013 | 2011 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 125,606 | 0 | 0 | 18,389 | 716,721 |
| Friday, March 15th, 2013 | 2012 | Marc S. Hanover President and Chief Operating Officer | 475,020 | 0 | 0 | 151,531 | 20,115 | 796,284 |
| Friday, March 15th, 2013 | 2010 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 0 | 0 | 0 | 12,910 | 404,090 |
| Friday, March 15th, 2013 | 2011 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 525,000 | 170,625 | 0 | 0 | 10,030 | 879,619 |
| Friday, March 15th, 2013 | 2010 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice- Chairman of the Board of Directors | 525,000 | 0 | 0 | 0 | 10,030 | 814,320 |
| Monday, March 12th, 2012 | 2011 | James T. Dalton, Ph.D. Vice President, Chief Scientific Officer Gregory A. Deener Former Vice President, Sales and Marketing | 128,496 | 0 | 0 | 0 | 134,696 | 680,128 |
| Friday, March 18th, 2011 | 2009 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 400,000 | 0 | 0 | 0 | 0 | 689,165 |
| Friday, March 18th, 2011 | 2008 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 283,889 | 0 | 0 | 0 | 0 | 566,666 |
| Friday, March 18th, 2011 | 2010 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 0 | 0 | 0 | 0 | 404,090 |
| Friday, March 18th, 2011 | 2010 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 525,000 | 0 | 0 | 0 | 0 | 814,320 |
| Friday, March 18th, 2011 | 2008 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 311,875 | 0 | 0 | 0 | 0 | 632,775 |
| Friday, March 18th, 2011 | 2009 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 525,000 | 0 | 0 | 0 | 0 | 1,236,793 |
| Friday, March 18th, 2011 | 2008 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 500,000 | 0 | 0 | 0 | 0 | 710,967 |
| Friday, March 18th, 2011 | 2009 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 0 | 0 | 0 | 0 | 545,218 |
| Friday, March 18th, 2011 | 2010 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 0 | 0 | 0 | 0 | 661,332 |
| Friday, March 18th, 2011 | 2009 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 0 | 0 | 0 | 0 | 943,589 |
| Friday, March 18th, 2011 | 2008 | Marc S. Hanover President and Chief Operating Officer | 435,000 | 0 | 0 | 0 | 0 | 1,609,564 |
| Friday, March 18th, 2011 | 2010 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 452,025 | 0 | 0 | 0 | 0 | 577,342 |
| Friday, March 18th, 2011 | 2009 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 452,025 | 0 | 0 | 0 | 0 | 716,684 |
| Friday, March 18th, 2011 | 2008 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 430,500 | 28,000 | 0 | 0 | 0 | 794,226 |
| Friday, March 18th, 2011 | 2010 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 400,000 | 0 | 0 | 0 | 0 | 509,506 |
| Thursday, March 18th, 2010 | 2009 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 525,000 | 0 | 0 | 0 | 0 | 1,236,793 |
| Thursday, March 18th, 2010 | 2008 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 500,000 | 0 | 0 | 0 | 0 | 710,967 |
| Thursday, March 18th, 2010 | 2007 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 446,250 | 0 | 0 | 0 | 0 | 579,794 |
| Thursday, March 18th, 2010 | 2008 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 311,875 | 0 | 0 | 0 | 0 | 632,775 |
| Thursday, March 18th, 2010 | 2008 | Marc S. Hanover President and Chief Operating Officer | 435,000 | 0 | 0 | 0 | 0 | 1,609,564 |
| Thursday, March 18th, 2010 | 2007 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 260,000 | 0 | 0 | 0 | 0 | 586,007 |
| Thursday, March 18th, 2010 | 2008 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 283,889 | 0 | 0 | 0 | 0 | 566,666 |
| Thursday, March 18th, 2010 | 2008 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 430,500 | 28,000 | 0 | 0 | 0 | 794,226 |
| Thursday, March 18th, 2010 | 2007 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 294,885 | 0 | 0 | 0 | 0 | 1,222,574 |
| Thursday, March 18th, 2010 | 2007 | Marc S. Hanover President and Chief Operating Officer | 306,600 | 0 | 0 | 0 | 0 | 394,207 |
| Thursday, March 18th, 2010 | 2007 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 246,750 | 0 | 0 | 0 | 0 | 580,487 |
| Thursday, March 18th, 2010 | 2009 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 452,025 | 0 | 0 | 0 | 0 | 716,684 |
| Thursday, March 18th, 2010 | 2009 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 400,000 | 0 | 0 | 0 | 0 | 689,165 |
| Thursday, March 18th, 2010 | 2009 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 298,083 | 0 | 0 | 0 | 0 | 545,218 |
| Thursday, March 18th, 2010 | 2009 | Marc S. Hanover President and Chief Operating Officer | 456,750 | 0 | 0 | 0 | 0 | 943,589 |
| Friday, March 20th, 2009 | 2008 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 430,500 | 28,000 | 0 | 105,903 | 29,200 | 801,198 |
| Friday, March 20th, 2009 | 2007 | Marc S. Hanover President and Chief Operating Officer | 306,600 | 0 | 0 | 77,263 | 10,344 | 394,207 |
| Friday, March 20th, 2009 | 2007 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 246,750 | 0 | 0 | 66,623 | 9,226 | 490,883 |
| Friday, March 20th, 2009 | 2006 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 236,692 | 12,338 | 0 | 0 | 3,941 | 382,470 |
| Friday, March 20th, 2009 | 2008 | Marc S. Hanover President and Chief Operating Officer | 435,000 | 0 | 0 | 158,558 | 12,893 | 806,854 |
| Friday, March 20th, 2009 | 2006 | Marc S. Hanover President and Chief Operating Officer | 293,891 | 30,660 | 0 | 0 | 495 | 325,046 |
| Friday, March 20th, 2009 | 2007 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 294,885 | 0 | 0 | 71,094 | 20,397 | 498,052 |
| Friday, March 20th, 2009 | 2007 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 260,000 | 0 | 0 | 59,280 | 8,839 | 449,759 |
| Friday, March 20th, 2009 | 2006 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 241,772 | 0 | 0 | 0 | 24,278 | 347,597 |
| Friday, March 20th, 2009 | 2008 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 500,000 | 0 | 0 | 202,500 | 8,467 | 710,967 |
| Friday, March 20th, 2009 | 2007 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 446,250 | 0 | 0 | 128,520 | 5,024 | 579,794 |
| Friday, March 20th, 2009 | 2006 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 427,055 | 44,625 | 0 | 0 | 653 | 472,333 |
| Friday, March 20th, 2009 | 2006 | Ronald A. Morton, Jr., M.D., F.A.C.S. Vice President, Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| Friday, March 20th, 2009 | 2008 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 283,889 | 0 | 0 | 70,263 | 11,891 | 574,412 |
| Friday, March 20th, 2009 | 2008 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 311,875 | 0 | 0 | 77,189 | 43,088 | 594,348 |
| Wednesday, March 12th, 2008 | 2007 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 446,250 | 0 | 0 | 0 | 0 | 579,794 |
| Wednesday, March 12th, 2008 | 2006 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 236,692 | 12,338 | 0 | 0 | 0 | 378,935 |
| Wednesday, March 12th, 2008 | 2006 | Ronald A. Morton, Jr., M.D., F.A.C.S. | 0 | 0 | 0 | 0 | 0 | 0 |
| Wednesday, March 12th, 2008 | 2007 | Ronald A. Morton, Jr., M.D., F.A.C.S. | 294,885 | 0 | 0 | 0 | 0 | 498,052 |
| Wednesday, March 12th, 2008 | 2006 | Marc S. Hanover President and Chief Operating Officer | 293,891 | 30,660 | 0 | 0 | 0 | 325,046 |
| Wednesday, March 12th, 2008 | 2006 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 427,055 | 44,625 | 0 | 0 | 0 | 472,333 |
| Wednesday, March 12th, 2008 | 2007 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 246,750 | 0 | 0 | 0 | 0 | 490,883 |
| Wednesday, March 12th, 2008 | 2006 | Henry P. Doggrell Vice President, General Counsel and Secretary | 254,835 | 13,283 | 0 | 0 | 0 | 371,832 |
| Wednesday, March 12th, 2008 | 2007 | Henry P. Doggrell Vice President, General Counsel and Secretary | 265,650 | 0 | 0 | 0 | 0 | 458,940 |
| Wednesday, March 12th, 2008 | 2007 | Marc S. Hanover President and Chief Operating Officer | 306,600 | 0 | 0 | 0 | 0 | 394,207 |
| Wednesday, March 14th, 2007 | 2006 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 241,772 | 0 | 0 | 0 | 20,414 | 343,733 |
| Wednesday, March 14th, 2007 | 2006 | Henry P. Doggrell Vice President, General Counsel and Secretary | 254,835 | 13,283 | 0 | 0 | 423 | 371,832 |
| Wednesday, March 14th, 2007 | 2006 | Mark E. Mosteller, CPA Vice President, Chief Financial Officer and Treasurer | 236,692 | 12,338 | 0 | 0 | 406 | 378,935 |
| Wednesday, March 14th, 2007 | 2006 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 427,055 | 44,625 | 0 | 0 | 653 | 472,333 |
| Wednesday, March 14th, 2007 | 2006 | Marc S. Hanover President and Chief Operating Officer | 293,891 | 30,660 | 0 | 0 | 495 | 325,046 |
| Wednesday, March 8th, 2006 | 2005 | K. Gary Barnette, Ph.D. Vice President, Clinical Research and Development Strategy | 225,438 | 0 | 0 | 0 | 0 | 225,438 |
| Wednesday, March 8th, 2006 | 2005 | Marc S. Hanover President and Chief Operating Officer | 263,033 | 0 | 0 | 0 | 0 | 263,033 |
| Wednesday, March 8th, 2006 | 2003 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 311,666 | 0 | 0 | 0 | 0 | 311,666 |
| Wednesday, March 8th, 2006 | 2003 | Marc S. Hanover President and Chief Operating Officer | 180,000 | 0 | 0 | 0 | 0 | 180,000 |
| Wednesday, March 8th, 2006 | 2004 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 375,000 | 0 | 0 | 0 | 0 | 375,000 |
| Wednesday, March 8th, 2006 | 2005 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 390,507 | 0 | 0 | 0 | 0 | 390,507 |
| Wednesday, March 8th, 2006 | 2003 | Henry P. Doggrell Vice President, General Counsel and Secretary | 193,000 | 0 | 0 | 0 | 0 | 193,000 |
| Wednesday, March 8th, 2006 | 2003 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 0 | 0 | 0 | 0 | 24,000 | 24,000 |
| Wednesday, March 8th, 2006 | 2003 | K. Gary Barnette, Ph.D. Vice President, Clinical Research and Development Strategy | 172,629 | 0 | 0 | 0 | 0 | 172,629 |
| Wednesday, March 8th, 2006 | 2004 | Henry P. Doggrell Vice President, General Counsel and Secretary | 211,583 | 0 | 0 | 0 | 0 | 211,583 |
| Wednesday, March 8th, 2006 | 2005 | Henry P. Doggrell Vice President, General Counsel and Secretary | 235,514 | 0 | 0 | 0 | 0 | 235,514 |
| Wednesday, March 8th, 2006 | 2004 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 0 | 0 | 0 | 0 | 24,000 | 24,000 |
| Wednesday, March 8th, 2006 | 2005 | James T. Dalton, Ph.D. Vice President, Preclinical Research and Development | 231,945 | 50,000 | 0 | 0 | 0 | 281,945 |
| Wednesday, March 8th, 2006 | 2004 | K. Gary Barnette, Ph.D. Vice President, Clinical Research and Development Strategy | 190,000 | 0 | 0 | 0 | 0 | 190,000 |
| Wednesday, March 8th, 2006 | 2004 | Marc S. Hanover President and Chief Operating Officer | 215,000 | 0 | 0 | 0 | 0 | 215,000 |
| Monday, March 28th, 2005 | 2003 | Henry P. Doggrell Vice President, General Counsel and Secretary | 193,000 | 0 | 0 | 0 | 0 | 193,000 |
| Monday, March 28th, 2005 | 2002 | Mark E. Mosteller Vice President and Chief Financial Officer | 135,417 | 0 | 0 | 0 | 0 | 135,417 |
| Monday, March 28th, 2005 | 2002 | Henry P. Doggrell Vice President, General Counsel and Secretary | 178,750 | 0 | 0 | 0 | 0 | 178,750 |
| Monday, March 28th, 2005 | 2004 | Henry P. Doggrell Vice President, General Counsel and Secretary | 211,583 | 0 | 0 | 0 | 0 | 211,583 |
| Monday, March 28th, 2005 | 2003 | Marc S. Hanover President and Chief Operating Officer | 180,000 | 0 | 0 | 0 | 0 | 180,000 |
| Monday, March 28th, 2005 | 2004 | Marc S. Hanover President and Chief Operating Officer | 215,000 | 0 | 0 | 0 | 0 | 215,000 |
| Monday, March 28th, 2005 | 2002 | Marc S. Hanover President and Chief Operating Officer | 180,000 | 0 | 0 | 0 | 0 | 180,000 |
| Monday, March 28th, 2005 | 2004 | Mark E. Mosteller Vice President and Chief Financial Officer | 174,583 | 0 | 0 | 0 | 0 | 174,583 |
| Monday, March 28th, 2005 | 2003 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 311,666 | 0 | 0 | 0 | 0 | 311,666 |
| Monday, March 28th, 2005 | 2004 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 375,000 | 0 | 0 | 0 | 0 | 375,000 |
| Monday, March 28th, 2005 | 2003 | Mark E. Mosteller Vice President and Chief Financial Officer | 154,167 | 0 | 0 | 0 | 0 | 154,167 |
| Monday, March 28th, 2005 | 2002 | Mitchell S. Steiner, M.D., F.A.C.S. Chief Executive Officer and Vice-Chairman of the Board of Directors | 175,000 | 0 | 0 | 0 | 0 | 175,000 |